We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Verseon (DI) | LSE:VSN | London | Ordinary Share | COM USD0.001 (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 74.00 | 70.00 | 78.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMVSN
RNS Number : 0020F
Verseon Corporation
24 October 2018
Press release October 24, 2018
Verseon Corporation
("Verseon" or the "Company")
Announcement of 2018 Annual General Meeting
FREMONT, Calif.-Verseon Corporation (AIM:VSN), a technology-based pharmaceutical company, announces that its 2018 Annual General Meeting ("AGM") will be held on November 05, 2018 at 2 p.m. local time at the Critosphere Cowork Space, 7100 Stevenson Blvd. Fremont, CA 94538, USA.
Copies of the following AGM documents will be available to view and download between October 23, 2018 and November 05, 2018 from the Company's website at https://www.verseon.com/investor-notices/agm2018:
-- Notice of 2018 Annual General Meeting of Shareholders -- 2018 AGM Proxy Information Statement -- Electronic Consent form
- Ends -
For further information, please contact
Hot Features
Premium
Verseon Corporation www.verseon.com
Sebastian Wykeham +1 (510) 225 9000
Arden Partners (NOMAD and Joint Broker)
Ruari McGirr / Paul Shackleton / +44 (0) 20 7614
Maria Gomez De Olea 5900
Cantor Fitzgerald Europe (Joint Broker)
+44 (0) 20 7894
Marc Milmo / Phil Davies / Callum Butterfield 7000
For financial and business media enquiries, please contact
Buchanan Communications Ltd (PR Advisers)
+44 (0) 20 7466
Henry Harrison-Topham / Jamie Hooper 5000
For trade and pharma media enquiries, please contact
Vane Percy & Roberts
+44 (0) 1737 821
Simon Vane Percy 890
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
NOAFKQDPPBDKBKB
(END) Dow Jones Newswires
October 24, 2018 02:00 ET (06:00 GMT)
1 Year Verseon Chart |
1 Month Verseon Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
